Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-10

Clinical Trial Update: Scandinavian Starch for Severe Sepsis/Septic Shock Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Scandinavian Starch for severe sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Scandinavian Starch (hydroxyethyl starch)

Snippet

Sponsor: Anders Perner | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: COMPLETED